Inventor · disambiguated record
David B. Olsen
Also filed as: OLSEN DAVID · OLSEN DAVID B · OLSEN DAVID BRIAN
37 granted patents·29 pending applications·2,513 citations·filing 1991–2022
98Inventor score
Files withMERCK SHARP & DOHME16MERCK & CO INC13MERCK SHARP & DOHME LLC6GIRIJAVALLABHAN VINAY3MAX PLANCK GESELLSCHAFT3
Top patents by PatentIndex Score
66 records- 0198US7202224B2Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymeraseISIS PHARMACEUTICALS INC·Filed 2006·Granted Apr 10, 2007·222 cites·1 claims
- 0298US7125855B2Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymeraseMERCK & CO INC·Filed 2003·Granted Oct 24, 2006·301 cites·4 claims
- 0398US7105499B2Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymeraseISIS PHARMACEUTICALS INC·Filed 2002·Granted Sep 12, 2006·233 cites·2 claims
- 0498US6777395B2Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virusMERCK & CO INC·Filed 2002·Granted Aug 17, 2004·356 cites·13 claims
- 0597US7470664B2HCV NS3 protease inhibitorsMERCK & CO INC·Filed 2006·Granted Dec 30, 2008·81 cites·40 claims
- 0696US5672695AModified ribozymesMAX PLANCK GESELLSCHAFT·Filed 1991·Granted Sep 30, 1997·382 cites·26 claims
- 0795US7879815B2Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infectionMERCK SHARP & DOHME·Filed 2007·Granted Feb 1, 2011·132 cites·18 claims
- 0894US9156872B22′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesGIRIJAVALLABHAN VINAY·Filed 2012·Granted Oct 13, 2015·45 cites·21 claims
- 0994US9061041B22′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesGIRIJAVALLABHAN VINAY·Filed 2012·Granted Jun 23, 2015·49 cites·43 claims
- 1094US7323453B2Methods of inhibiting orthopoxvirus replication with nucleoside compoundsMERCK & CO INC·Filed 2003·Granted Jan 29, 2008·71 cites·27 claims
- 1193US7632821B2Ribonucleoside cyclic acetal derivatives for the treatment of RNA-dependent RNA viral infectionMERCK & CO INC·Filed 2006·Granted Dec 15, 2009·67 cites·15 claims
- 1292US7323449B2Thionucleoside derivatives as inhibitors of RNA-dependent RNA viral polymeraseMERCK & CO INC·Filed 2003·Granted Jan 29, 2008·58 cites·15 claims
- 1391US8216999B2HCV NS3 protease inhibitorsHOLLOWAY M KATHARINE·Filed 2008·Granted Jul 10, 2012·26 cites·18 claims
- 1491US7879797B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2006·Granted Feb 1, 2011·15 cites·16 claims
- 1590US10947205B2Oxazolidinone compounds and methods of use thereof as antibacterial agentsMERCK SHARP & DOHME·Filed 2019·Granted Mar 16, 2021·5 cites·11 claims
- 1690US5861501ACapped synthetic RNA, analogs, and aptamersMERCK & CO INC·Filed 1997·Granted Jan 19, 1999·115 cites·2 claims
- 1790US5698687AModified ribozymlsMAX PLANCK GESELLSCHAFT·Filed 1995·Granted Dec 16, 1997·95 cites·37 claims
- 1889US8278322B2HCV NS3 protease inhibitorsHOLLOWAY M KATHARINE·Filed 2006·Granted Oct 2, 2012·10 cites·40 claims
- 1989US6111095ACapped synthetic RNA, analogs, and aptamersMERCK & CO INC·Filed 1995·Granted Aug 29, 2000·76 cites·43 claims
- 2087US9777035B24′-substituted nucleoside reverse transcriptase inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 3, 2017·10 cites·59 claims
- 2187US9150603B22′-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseasesGIRIJAVALLABHAN VINAY·Filed 2012·Granted Oct 6, 2015·14 cites·21 claims
- 2286US5817635AModified ribozymesMAX PLANCK GES EV·Filed 1995·Granted Oct 6, 1998·88 cites·42 claims
- 2381US12338219B2Antimalarial agentsMERCK SHARP & DOHME LLC·Filed 2020·Granted Jun 24, 2025·1 cites·16 claims
- 2476US12350270B2Antimalarial agentsMERCK SHARP & DOHME LLC·Filed 2020·Granted Jul 8, 2025·1 cites·52 claims
- 2576US9416154B25′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesVERMA VISHAL A·Filed 2012·Granted Aug 16, 2016·4 cites·19 claims
- 2676US6369208B1Capped synthetic RNA, analogs, and aptamersMERCK & CO INC·Filed 1996·Granted Apr 9, 2002·32 cites·20 claims
- 2768US9765107B2Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2014·Granted Sep 19, 2017·1 cites·13 claims
- 2867US12459933B2Compounds and methods of use thereof as antibacterial agentsMERCK SHARP & DOHME LLC·Filed 2020·Granted Nov 4, 2025·0 cites·32 claims
- 2965US2021379020A1Compounds for the treatment of malariaMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 3064US2021061777A1Oxazolidinone compounds and methods of use thereof as antibacterial agentsMERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
- 3162US12435077B2Oxazolidinone compound and methods of use thereof as an antibacterial agentMERCK SHARP & DOHME LLC·Filed 2021·Granted Oct 7, 2025·0 cites·24 claims
- 3260US2007179114A1Novel 2'-C methyl nucleoside derivativesMERCK & CO INC·Filed 2006·Application pending·0 cites
- 3359US2017183373A1Nucleoside derivatives as inhibitors of rna-dependent rna viral polyermaseMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 3459US2006205686A1Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymeraseBHAT BALKRISHEN·Filed 2005·Application pending·0 cites
- 3557US2019046507A1Compounds for the treatment of malariaMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 3657US2020223220A1Compounds for the treatment of malariaMERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
- 3755US10144741B2Nargenicin compounds and uses thereof as antibacterial agentsMERCK SHARP & DOHME·Filed 2018·Granted Dec 4, 2018·0 cites·13 claims
- 3854US6100028ADNA polymerase extension assayMERCK & CO INC·Filed 1996·Granted Aug 8, 2000·16 cites·6 claims
- 3954US2016243128A1Polycyclic heterocycle derivatives and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2016·Application pending·0 cites
- 4053US2011111976A1Microrna biomarkers of tissue injuryMERCK SHARP & DOHME·Filed 2009·Application pending·0 cites
- 4152US9944654B2Nargenicin compounds and uses thereof as antibacterial agentsMERCK SHARP & DOHME·Filed 2015·Granted Apr 17, 2018·0 cites·15 claims
- 4251US2010143886A1In vivo hcv resistance to anti-viral inhibitorsLUDMERER STEVEN W·Filed 2008·Application pending·0 cites
- 4349US2013280214A1Polycyclic heterocycle derivatives and methods of use thereof for the treatment of viral diseasesVACCA JOSEPH P·Filed 2011·Application pending·0 cites
- 4449US2004259934A1Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compoundsFiled 2004·Application pending·0 cites
- 4548US2009203008A1Rapid method to determine inhibitor sensitivity of NS3/4A protease sequences cloned from clinical samplesLUDMERER STEVEN W·Filed 2007·Application pending·0 cites
- 4647US12365656B2Oxazolidinone compounds and methods of use thereof as antibacterial agentsMERCK SHARP & DOHME LLC·Filed 2019·Granted Jul 22, 2025·0 cites·17 claims
- 4747US2007004669A1Nucleoside derivatives as inhibitors of rna-dependent rna viral polymeraseCARROLL STEVEN S·Filed 2003·Application pending·0 cites
- 4847US2004229840A1Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymeraseFiled 2003·Application pending·0 cites
- 4946US2018002366A14'-substituted nucleoside reverse transcriptase inhibitorsMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 5045US11766435B2N3-substituted iminopyrimidinones as antimalarial agentsMERCK SHARP & DOHME LLC·Filed 2017·Granted Sep 26, 2023·0 cites·6 claims
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David B. Olsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →